Pfizer stories
Fivetran has appointed Simon Quinton as General Manager for EMEA, with Suresh Seshadri as CFO and Anand Mehta as Chief People Officer, to boost growth.
Celonis is revolutionising business efficiency with innovative process mining, bridging data gaps to enable AI-driven optimisation across industries.
Harte Hanks has unveiled Demand Generation In a Box, a comprehensive service aimed at helping SMEs enhance brand interest and drive lead generation efficiently.
Aussie and Kiwi companies lauded at the Adobe Experience Maker awards for their digital innovation, securing three major accolades.
Adobe debuts AI-driven innovations to enhance content supply chain, streamlining end-to-end business processes and delivering personalised customer experiences.
Immersive Labs named a leader in cybersecurity skills and training platforms by the Forrester Wave: Cybersecurity Skills and Training Platforms, Q4 2023.
PureCloud is built on a microservices framework that delivers customer engagement and employee collaboration functionality.
Wall Street moved lower as an unexpected gain in new home sales as well as solid data on inflation and manufacturing bolstered the case for the Federa.
Wall Street gained along with the price of oil and shares of Pfizer after it agreed to buy Hospira for about US$15 billion, while the latest US job.
PharmX has expanded its platform with 15 new suppliers, increasing its total offerings to over 80,000 SKUs across its Gateway and Marketplace solutions.
Pfizer has teamed up with Ignition AI Accelerator to boost drug discovery using AI, aiming to bring innovative treatments to market more quickly.
Immersive Labs has appointed Eric Johnson as CRO and Julie Chapman as SVP of Customer Experience to drive global revenue growth and customer acquisition.
Booster shots are now seen as the best way to curb Omicron, as experts say prior infection alone may not provide enough protection.
The model could help authorities prioritise scarce doses by targeting places visited by likely superspreaders, researchers say.
A major study finds 30 minutes’ activity five days a week could prevent one in 12 deaths worldwide, especially in lower-income countries.
Complexica recently announced that it has won a tender at Pfizer Australia for the deployment of it's What-if Simulator.
